Mark S Rouse
Overview
Explore the profile of Mark S Rouse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
546
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Del Pozo J, Rouse M, Euba G, Greenwood-Quaintance K, Mandrekar J, Steckelberg J, et al.
J Appl Biomater Funct Mater
. 2014 Aug;
12(2):81-3.
PMID: 25097026
A technique for the prevention of staphylococcal adhesion by electrical current exposure was investigated. Teflon coupons were exposed to a continuous flow of 103 cfu/ml Staphylococcus epidermidis with or without...
2.
Zhao H, Kang C, Rouse M, Patel R, Kita H, Juhn Y
Int J Microbiol
. 2011 Dec;
2011:709509.
PMID: 22164165
Interleukin- (IL-) 17 is important in the development of asthma and host defense against pneumococci. We determined the role of IL-17 in the risk of pneumococcal pneumonia. We challenged mice...
3.
Vergidis P, Rouse M, Euba G, Karau M, Schmidt S, Mandrekar J, et al.
Antimicrob Agents Chemother
. 2010 Dec;
55(3):1182-6.
PMID: 21189340
Rifampin monotherapy was compared to the combination of linezolid or vancomycin with rifampin in an experimental rat model of methicillin-resistant Staphylococcus aureus (MRSA) chronic foreign body osteomyelitis. MRSA was inoculated...
4.
Rouse M, Heijink A, Steckelberg J, Patel R
Clin Orthop Relat Res
. 2010 Oct;
469(5):1466-9.
PMID: 20963525
Background: Depot delivery of antimicrobial agents is used for treatment and prevention of bacterial orthopaedic infections; there is little information regarding newer antifungal agents and their potential use in polymethylmethacrylate...
5.
Del Pozo J, Rouse M, Euba G, Kang C, Mandrekar J, Steckelberg J, et al.
Antimicrob Agents Chemother
. 2009 Aug;
53(10):4064-8.
PMID: 19651912
Treatment with low-amperage (200 microA) electrical current was compared to intravenous doxycycline treatment or no treatment in a rabbit model of Staphylococcus epidermidis chronic foreign body osteomyelitis to determine if...
6.
Kang C, Rouse M, Mandrekar J, Steckelberg J, Patel R
Antimicrob Agents Chemother
. 2009 Jun;
53(8):3576-8.
PMID: 19506064
We established a murine model of Candida albicans central nervous system (CNS) infection and evaluated the efficacy of anidulafungin. Ten milligrams/kg/day anidulafungin, amphotericin B, or voriconazole significantly reduced mortality and...
7.
Fernandez Sampedro M, Piper K, McDowell A, Patrick S, Mandrekar J, Rouse M, et al.
Diagn Microbiol Infect Dis
. 2009 Jun;
64(2):138-45.
PMID: 19505429
Propionibacterium sp. is commonly isolated in association with orthopedic implants, either as a pathogen or a colonizer. Microbial characteristics that indicate whether the isolated species is a likely cause of...
8.
Mook-Kanamori B, Rouse M, Kang C, van de Beek D, Steckelberg J, Patel R
BMC Infect Dis
. 2009 May;
9:50.
PMID: 19405978
Background: Daptomycin, a lipopeptide antibiotic, could be an alternative to vancomycin for treatment of pneumococcal meningitis. We determined the activity of daptomycin versus vancomycin, with dexamethasone as an adjuvant, in...
9.
Del Pozo J, Rouse M, Mandrekar J, Steckelberg J, Patel R
Antimicrob Agents Chemother
. 2008 Oct;
53(1):41-5.
PMID: 18955534
The activity of electrical current against planktonic bacteria has previously been demonstrated. The short-term exposure of the bacteria in biofilms to electrical current in the absence of antimicrobials has been...
10.
Del Pozo J, Rouse M, Mandrekar J, Fernandez Sampedro M, Steckelberg J, Patel R
Antimicrob Agents Chemother
. 2008 Aug;
53(1):35-40.
PMID: 18725436
Bacterial biofilms are resistant to conventional antimicrobial agents. Prior in vitro studies have shown that electrical current (EC) enhances the activities of aminoglycosides, quinolones, and oxytetracycline against Pseudomonas aeruginosa, Klebsiella...